These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 22161815)

  • 1. The epigenetic promise for prostate cancer diagnosis.
    Van Neste L; Herman JG; Otto G; Bigley JW; Epstein JI; Van Criekinge W
    Prostate; 2012 Aug; 72(11):1248-61. PubMed ID: 22161815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The usefulness of the detection of GSTP1 methylation in urine as a biomarker in the diagnosis of prostate cancer.
    Woodson K; O'Reilly KJ; Hanson JC; Nelson D; Walk EL; Tangrea JA
    J Urol; 2008 Feb; 179(2):508-11; discussion 511-2. PubMed ID: 18076912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preoperative serum DNA GSTP1 CpG island hypermethylation and the risk of early prostate-specific antigen recurrence following radical prostatectomy.
    Bastian PJ; Palapattu GS; Lin X; Yegnasubramanian S; Mangold LA; Trock B; Eisenberger MA; Partin AW; Nelson WG
    Clin Cancer Res; 2005 Jun; 11(11):4037-43. PubMed ID: 15930338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multigene methylation analysis for detection and staging of prostate cancer.
    Enokida H; Shiina H; Urakami S; Igawa M; Ogishima T; Li LC; Kawahara M; Nakagawa M; Kane CJ; Carroll PR; Dahiya R
    Clin Cancer Res; 2005 Sep; 11(18):6582-8. PubMed ID: 16166436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular detection of prostate cancer: a role for GSTP1 hypermethylation.
    Henrique R; Jerónimo C
    Eur Urol; 2004 Nov; 46(5):660-9; discussion 669. PubMed ID: 15474280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GSTP1 hypermethylation as a molecular marker in the diagnosis of prostatic cancer: is there a correlation with clinical stage, Gleason grade, PSA value or age?
    Bastian PJ; Ellinger J; Schmidt D; Wernert N; Wellmann A; Müller SC; von Rücker A
    Eur J Med Res; 2004 Nov; 9(11):523-7. PubMed ID: 15649863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methylated genes as potential biomarkers in prostate cancer.
    Phé V; Cussenot O; Rouprêt M
    BJU Int; 2010 May; 105(10):1364-70. PubMed ID: 20067451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Promoter hypermethylation as an independent prognostic factor for relapse in patients with prostate cancer following radical prostatectomy.
    Rosenbaum E; Hoque MO; Cohen Y; Zahurak M; Eisenberger MA; Epstein JI; Partin AW; Sidransky D
    Clin Cancer Res; 2005 Dec; 11(23):8321-5. PubMed ID: 16322291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CpG island hypermethylation in cell-free serum DNA identifies patients with localized prostate cancer.
    Ellinger J; Haan K; Heukamp LC; Kahl P; Büttner R; Müller SC; von Ruecker A; Bastian PJ
    Prostate; 2008 Jan; 68(1):42-9. PubMed ID: 18004747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative GSTP1 methylation clearly distinguishes benign prostatic tissue and limited prostate adenocarcinoma.
    Harden SV; Guo Z; Epstein JI; Sidransky D
    J Urol; 2003 Mar; 169(3):1138-42. PubMed ID: 12576869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The emerging roles of DNA methylation in the clinical management of prostate cancer.
    Perry AS; Foley R; Woodson K; Lawler M
    Endocr Relat Cancer; 2006 Jun; 13(2):357-77. PubMed ID: 16728568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Detection of DNA hypermethylation as a potential biomarker for prostate cancer].
    Tilandyová P; Kajo K; Kliment J; Plank L; Lasabová Z
    Klin Onkol; 2010; 23(5):293-9. PubMed ID: 21061679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GSTP1 CpG island hypermethylation as a molecular biomarker for prostate cancer.
    Nakayama M; Gonzalgo ML; Yegnasubramanian S; Lin X; De Marzo AM; Nelson WG
    J Cell Biochem; 2004 Feb; 91(3):540-52. PubMed ID: 14755684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostate cancer detection by GSTP1 methylation analysis of postbiopsy urine specimens.
    Gonzalgo ML; Pavlovich CP; Lee SM; Nelson WG
    Clin Cancer Res; 2003 Jul; 9(7):2673-7. PubMed ID: 12855646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversal of GSTP1 CpG island hypermethylation and reactivation of pi-class glutathione S-transferase (GSTP1) expression in human prostate cancer cells by treatment with procainamide.
    Lin X; Asgari K; Putzi MJ; Gage WR; Yu X; Cornblatt BS; Kumar A; Piantadosi S; DeWeese TL; De Marzo AM; Nelson WG
    Cancer Res; 2001 Dec; 61(24):8611-6. PubMed ID: 11751372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic and prognostic information in prostate cancer with the help of a small set of hypermethylated gene loci.
    Bastian PJ; Ellinger J; Wellmann A; Wernert N; Heukamp LC; Müller SC; von Ruecker A
    Clin Cancer Res; 2005 Jun; 11(11):4097-106. PubMed ID: 15930345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glutathione S-transferase pi (GSTP1) hypermethylation in prostate cancer: review 2007.
    Meiers I; Shanks JH; Bostwick DG
    Pathology; 2007 Jun; 39(3):299-304. PubMed ID: 17558856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined hypermethylation of APC and GSTP1 as a molecular marker for prostate cancer: quantitative pyrosequencing analysis.
    Yoon HY; Kim SK; Kim YW; Kang HW; Lee SC; Ryu KH; Shon HS; Kim WJ; Kim YJ
    J Biomol Screen; 2012 Aug; 17(7):987-92. PubMed ID: 22511308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Promoter hypermethylation of GSTP1, AR, and 14-3-3sigma in serum of prostate cancer patients and its clinical relevance.
    Reibenwein J; Pils D; Horak P; Tomicek B; Goldner G; Worel N; Elandt K; Krainer M
    Prostate; 2007 Mar; 67(4):427-32. PubMed ID: 17192910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formamide as a denaturant for bisulfite conversion of genomic DNA: Bisulfite sequencing of the GSTPi and RARbeta2 genes of 43 formalin-fixed paraffin-embedded prostate cancer specimens.
    Zon G; Barker MA; Kaur P; Groshen S; Jones LW; Imam SA; Boyd VL
    Anal Biochem; 2009 Sep; 392(2):117-25. PubMed ID: 19505431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.